Skip to main content
Livermore
Livermore
ZHEN

Private Advisor Group, LLC

SEC CIK
0001567755
Latest filing
Jul 27, 2026

HALO holding history

Halozyme Therapeutics, Inc. in every 13F filed by Private Advisor Group, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

HALO overviewAll 13F holders of HALOFull Q2 2026 holdings

Shares (Q4 2025)
0
Sold out in Q4 2025
Value
$0
% of portfolio
0.0%
Quarters held
19
Since Q1 2021
Holdings of HALO by Private Advisor Group, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20250$00.0%−23,623−100.0%Sold outHolders
Q3 202523,623$1.73M<0.1%+184+0.8%AddedHolders
Q2 202523,439$1.22M<0.1%−6,061−20.5%ReducedHolders
Q1 202529,500$1.88M<0.1%−408−1.4%ReducedHolders
Q4 202429,908$1.43M<0.1%+5,745+23.8%AddedHolders
Q3 202424,163$1.38M<0.1%+1,410+6.2%AddedHolders
Q2 202422,753$1.19M<0.1%+412+1.8%AddedHolders
Q1 202422,341$908.8K<0.1%−1,110−4.7%ReducedHolders
Q4 202323,451$866.8K<0.1%+1,377+6.2%AddedHolders
Q3 202322,074$843.2K<0.1%+130+0.6%AddedHolders
Q2 202321,944$939.7K<0.1%+227+1.0%AddedHolders
Q1 202321,717$829.4K<0.1%00.0%UnchangedHolders
Q4 202221,717$1.22M0.1%−20,065−48.0%ReducedHolders
Q3 202241,782$1.65M<0.1%+170.0%AddedHolders
Q2 202241,765$1.84M<0.1%−70.0%ReducedHolders
Q1 202241,772$1.67M<0.1%−38−0.1%ReducedHolders
Q4 202141,810$1.68M<0.1%−41,424−49.8%ReducedHolders
Q3 202183,234$3.39M<0.1%+41,534+99.6%AddedHolders
Q2 202141,700$1.89M<0.1%00.0%UnchangedHolders
Q1 202141,700$1.74M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.